Page last updated: 2024-11-06

mitomycin and Mitochondrial Diseases

mitomycin has been researched along with Mitochondrial Diseases in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pagano, G1
Tiano, L1
Pallardó, FV1
Lyakhovich, A1
Mukhopadhyay, SS1
Di Bartolomeo, P1
Zatterale, A1
Trifuoggi, M1

Reviews

1 review available for mitomycin and Mitochondrial Diseases

ArticleYear
Re-definition and supporting evidence toward Fanconi Anemia as a mitochondrial disease: Prospects for new design in clinical management.
    Redox biology, 2021, Volume: 40

    Topics: Fanconi Anemia; Humans; Mitochondrial Diseases; Mitomycin; Phenotype; Proteins

2021